PGx of HCV
This test utilizes a platform for Pharmacogenetics of Hepatitis C virus NS5A developed by collaboration between GGA Corp. and TCM BioTech International Corp.
Hepatitis C is a potentially fatal liver disease caused by the hepatitis C virus (HCV). The disease affects more than 130 million people worldwide. It’s typically spread through the shared use of medical needles by intravenous drug users.
Genotype 1 is the most common HCV genotype. The FDA has approved some New Oral Hepatitis C Drugs, which according to clinical trials, has cured hepatitis C for over 90 percent of patients undergoing treatment. Although such treatment is promising, it is also costly. Genetic testing for HCV NS5A polymorphism is recommended prior to initiation of treatment.
If you are interested in this service, please leave a message on <Contact Us>.